- Home
- ECOR vs JFB Comparison
ECOR vs JFB Comparison
Compare ECOR & JFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- JFB
- Stock Information
- Founded
- ECOR 2005
- JFB 2014
- Country
- ECOR United States
- JFB United States
- Employees
- ECOR N/A
- JFB N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- JFB
- Sector
- ECOR Health Care
- JFB
- Exchange
- ECOR Nasdaq
- JFB NYSE
- Market Cap
- ECOR 40.1M
- JFB 37.0M
- IPO Year
- ECOR 2018
- JFB 2025
- Fundamental
- Price
- ECOR $6.02
- JFB $4.40
- Analyst Decision
- ECOR Strong Buy
- JFB
- Analyst Count
- ECOR 2
- JFB 0
- Target Price
- ECOR $25.50
- JFB N/A
- AVG Volume (30 Days)
- ECOR 130.4K
- JFB 20.3K
- Earning Date
- ECOR 05-07-2025
- JFB 01-01-0001
- Dividend Yield
- ECOR N/A
- JFB N/A
- EPS Growth
- ECOR N/A
- JFB N/A
- EPS
- ECOR N/A
- JFB 0.02
- Revenue
- ECOR $25,182,000.00
- JFB $23,087,885.00
- Revenue This Year
- ECOR $32.20
- JFB N/A
- Revenue Next Year
- ECOR $46.27
- JFB N/A
- P/E Ratio
- ECOR N/A
- JFB $288.56
- Revenue Growth
- ECOR 57.09
- JFB N/A
- 52 Week Low
- ECOR $5.02
- JFB $3.39
- 52 Week High
- ECOR $19.49
- JFB $4.87
- Technical
- Relative Strength Index (RSI)
- ECOR 33.07
- JFB N/A
- Support Level
- ECOR $5.20
- JFB N/A
- Resistance Level
- ECOR $6.47
- JFB N/A
- Average True Range (ATR)
- ECOR 0.71
- JFB 0.00
- MACD
- ECOR 0.33
- JFB 0.00
- Stochastic Oscillator
- ECOR 49.26
- JFB 0.00
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About JFB JFB CONSTRUCTION HOLDINGS
JFB Construction Holdings is a commercial and residential real estate construction and development company. It is engaged in retail corporate buildouts, multifamily community developments and luxury residential homes, with a focus on fostering long-term relationships with clients, partners, and communities. The company operates in three distinct business segments: Commercial Construction, Residential Construction, and Real Estate Development. Key revenue is generated from Commercial Construction: This segment includes all activities related to the construction of commercial properties such as office buildings, retail spaces, and industrial facilities.